PKDL Consortium meeting Kolkata, 28-29 November 2024

The Post-kala-azar dermal leishmaniasis (PKDL) Consortium was founded in 2012;  the 7th meeting was held in Kolkata, India. The Consortium aims to promote all aspects of PKDL both with regard to clinical management as well as control.

In the meeting, epidemiology and control, immunology, vaccines and immunotherapy, leishmania and co-infection, diagnosis and treatment were reviewed.

Kolkata meeting agenda, 23112024(1)

The meeting was covered in one of the local newspapers:

https://epaper.telegraphindia.com/calcutta/2024-11-29/71/Page-8.html

 

 

Introduction slides

To archive

Recent publications

Chatterjee M, Sengupta R, Cloots K, Zijlstra EE. Report of the Seventh Post-Kala-azar Dermal Leishmaniasis Consortium meeting, Kolkata, India, 28-29 November 2024
Zijlstra EE. Risk factors for post-kala-azar dermal leishmaniasis (PKDL): Challenges in understanding pathophysiology.
Zijlstra EE. Post kala-azar dermal leishmaniasis in East Africa, with focus on Sudan: Review of three decades of experience and research. Ann Med Sci Res 2025;4:S35-46.
View all publications

News

DTM&H Course, Bernard Nocht Institute, Hamburg, 16 April 2026

Presentations will be made on Visceral Leishmaniasis (VL, kala-azar) and Post-Kala-Azar Dermal Leishmaniasis (PKDL): epidemiology, entomology, clinical features, pathophys

> Read more